Stephen Mandel - Lone Pine Capital
Holding/activity history for Fate Therapeutics Inc (FATE)
← All FATE superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2021 Q4 | 0 | 0.00 | Sell 100.00% | 0.44 | $43.60–66.56 · VW $56.46i | SEC | |
| 2021 Q3 | 2,199,284 | 0.44 | Add 25.72% | 0.09 | $58.92–97.43 · VW $75.93i | $130,352,000 | SEC |
| 2021 Q2 | 1,749,284 | 0.49 | $86.79 | $151,820,000 | SEC | ||
| 2021 Q1 | 1,749,284 | 0.52 | Add 97.96% | 0.26 | $68.51–121.16 · VW $91.94i | $144,228,000 | SEC |
| 2020 Q4 | 883,666 | 0.29 | Buy | 0.29 | $38.02–103.66 · VW $66.56i | $80,352,000 | SEC |